Ruben A. Mesa, Lucia Masarova, Brandi Reeves, Zhijian Xiao, Albert Qin, Harinder Gill, Jie Jin, Norio Komatsu, Keita Kirito, Firas El Chaer, Lynda M. Foltz, Tsewang Tashi, Ghaith F. Abu Zeinah, Lee-Yung Shih, Dawn Maze, Stephen Oh, Oleh Zagrijtschuk, Toshiaki Sato, Abdulraheem Yacoub, John Mascarenhas. "Integrated analysis of the ropeginterferon alfa-2b clinical program in essential thrombocythemia to demonstrate molecular and hematologic responses with safety profile information across treatment lines, ethnicities, and driver mutation types.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.6576